title: Modification of lymphocyte subsets in Jessner's lymphocytic infiltration of the skin during proquazone treatment.
abstract: This study deals with 13 patients who volunteered for serial biopsies during proquazone treatment which proved to be effective in the majority of the cases. The immunocompetent cells in the inflammatory cell infiltrates were characterized by a panel of monoclonal antibodies: OKT11, OKT4, OKT8, OKT6, NK-9 and Leu-14. Before proquazone treatment there was only a slight predominance of OKT4-positive cells as compared to OKT8-positive cells but a rather high number of NK-9-positive natural killer or activated cytotoxic T cells. The pattern of inflammatory cell subclasses changed during the treatment and the most striking difference was the reduction in the number of the NK-9-positive cells. It is proposed that Jessner's lymphocytic infiltration of the skin (LIS) should be viewed as an entity and that proquazone possibly acts by modulating the pattern and activation stage of lymphocyte subclasses in LIS.
authors: Department of Dermatology, University Central Hospital, Helsinki, Finland.
authors: E A
authors: EA
authors: Johansson
authors: K M
authors: KM
authors: Niemi
authors: A
authors: A
authors: Ranki
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal; D002465:Cell Movement / Q000187:drug effects*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008214:Lymphocytes / Q000032:analysis / Q000145:classification* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D012008:Recurrence; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D011799:Quinazolines; C011385:proquazone